General fitness, health and nutrition · Public discussion

Re: Echinacea-The Herb Foundation

Started by Jan · · Last activity · 2 posts · 242 views

Thread details

What we know about this thread

Original section
General fitness, health and nutrition
Published
5 December 2003
Last activity
5 December 2003
Original author
Jan
Posts
2
Discussion status
Public discussion
Total views
242
Views / 30 days
0

The navigation and discussion metadata provide context. Posts remain in their original chronological order.

Showing posts 1–2 of 2
Posts remain in their original chronological order.

Text size
  1. NOT from organized medicine.

    The Herb Research Foundation:

    Echinacea

    Echinacea purpurea

    Echinacea, the purple coneflower, is the best
    known and researched herb for stimulating the
    immune system. Thousands of Europeans and Americans use echinacea
    preparations against colds and flu, minor
    infections, and a host of other major and minor ailments. This
    native American herb has an impressive record of
    laboratory and clinical research. Thousands of doctors currently use
    echinacea for treating infectious diseases.

    --------------------------------------------------------------------------
    ------

    Primary uses of echinacea; Colds, coughs and flu and other upper
    respiratory conditions, Enlarged lymph glands, sore
    throat, urinary tract infections, and other minor infections. May
    help combat herpes and candida, wounds, skin
    regeneration and skin infections (external use), Psoriasis, eczema
    and inflammatory skin conditions.

    --------------------------------------------------------------------------
    ------

    History... Echinacea has a rich tradition of use by North American
    Plains Indians who used it medicinally more than
    any other plant. It was prominent in modern American medicine in the
    early 20th Century, and was discovered by
    Europeans, who have used it extensively since the 1930s. Today
    millions of Europeans use echinacea as their primary
    therapy for colds, flus, infections, and for general immune-boosting
    effects.

    Health Benefits of Echinacea... Echinacea increases the
    "non-specific" activity of the immune system. In other words,
    unlike a vaccine which is active only against a specific disease,
    echinacea stimulates the overall activity of the cells
    responsible for fighting all kinds of infection. Unlike antibiotics,
    which are directly lethal to bacteria, echinacea makes
    our own immune cells more efficient in attacking bacteria, viruses
    and abnormal cells, including cancer cells.

    Echinacea facilitates wound healing, lessens symptoms of and speeds
    recovery from viruses. Anti-inflammatory effects
    make it useful externally against inflammatory skin conditions
    including psoriasis and eczema. It may also increase
    resistance to candida, bronchitis, herpes, and other infectious
    conditions.

    --------------------------------------------------------------------------
    ------

    State of Knowledge...

    Clinical (human) research Laboratory research History of use /
    Traditional use Safety record International acceptance
    Stars indicate level of knowledge on a scale from 0 - 5

    Research Findings... Over 500 scientific studies have documented the
    chemistry, pharmacology, and clinical
    applications of echinacea. The most consistently proven effect of
    echinacea is in stimulating phagocytosis, that is
    encouraging white blood cells and lymphocytes to attack invading
    organisms. Specific actions:

    increases the number and activity of immune system cells, including
    anti-tumor cells: promotes T-cell activation;
    stimulates new tissue growth for wound healing; reduces inflammation
    in arthritis and inflammatory skin conditions; Mild
    antibiotic action: bacteriostatic, anti-viral, anti-fungal. inhibits
    the bacterial enzyme hyaluronidase, to help prevent
    bacterial access to healthy cells. Specific Studies: Clinical Study:
    an extract of echinacea showed an increase of
    50%-120% in immune function over a 5 day period (Jurcic, et al.
    1989).

    Clinical Study: an extract of echinacea significantly increased the
    resistance to flu and reduced the symptoms of lymph
    gland swelling, inflamed nasal passages and headache (Braunig, et
    al. 1992).

    Clinical Study: Of 4500 patients with inflammatory skin conditions,
    including psoriasis, 85% were cured with topical
    applications of echinacea salve (Wacker & Hilbig, 1978).

    Laboratory Study: Human white blood cells, stimulated by echinacea
    extract increased phagocytosis (consumption) of
    yeast cells by 20-40% compared to controls. (Wagner and Proksch
    1985)
    --------------------------------------------------------------------------
    ------

    Safety... Echinacea has an excellent safety record and is very well
    tolerated by most people. There is no known
    toxicity. Echinacea should not be used in progressive systemic and
    auto-immune disorders such as tuberculosis,
    leicosis, connective tissue disorders, collagenosis and related
    diseases such as lupus, according to the German
    Kommission E. Its use in AIDS or opportunistic infections in AIDS
    patients is controversial.

    --------------------------------------------------------------------------
    ------

    Using Echinacea... Echinacea root is the part which has been used
    historically in European and American herbalism.
    Today nearly all parts of the plant are used, including the root,
    leaves, flowers, and seeds. Echinacea is available
    commercially in a number of forms - dried root or herb, liquid
    extract, powder, capsules and tablets, and creams and
    gels. Echinacea preparations are approved drugs in European
    countries. The officially recommended usage levels, and
    those used in research studies are:

    Liquid extracts (or tinctures): very popular forms for ease of use.
    May be alcohol- or glycerine-based. Extract strength
    varies, so following manufacturers' directions is important.
    Recommended amounts range from one to five droppersful
    per use (0.5-5 ml.) three times per day. Capsules or tablets: may
    contain root powder or herb. Recommended usage
    level: 1/2 - 2 g per use three times a day. Echinacea tea:. The
    usage level for root and/or herb brewed as a tea: 1/2 - 2
    g per use three times a day, Usage recommendations are from the
    British Herbal Pharmacopoeia and official sources
    from Germany (Kommission E and Standardzulassung).

    Important Note: With long-term use, echinacea appears to lose
    effectiveness. Maximum periods of continuous use: 6 -
    8 weeks. Echinacea is not a substitute for other medical
    interventions in rapidly accelerating infections. If the condition
    persists or worsens, seek medical advice. Many serious medical
    conditions are not appropriate for self-diagnosis or
    self-medication and require the supervision of qualified health care
    providers. Use caution when practicing self-care.

    --------------------------------------------------------------------------
    ------

    Recommended Reading Echinacea, Nature's Immune Enhancer by Stephen
    Foster. Healing Arts Press, 1991.
    Echinacea, the Immune Herb by Christopher Hobbs. Botanica Press,
    1990. Botanical Influences on Illness by Melvyn
    Werbach and Michael Murray. Third Line Press, 1994. See chapters on
    Cancer, Candidiasis, Immunodepression,
    Infection, Wound Healing. Herbal Medicine by Rudolf Weiss. AB
    Arcanum, 1988.

    Selected References British Herbal Pharmacopeia, 1992. Kommission E
    Monographs: Echinacea. Kooperation
    Phytopharmaka, , Germany. Jurcic, et al. Zeitschrift fur
    Phytotherapie 10 (2), 1989. Braunig, et al. Zeitschrift fur
    Phytotherapie 13: 7-13, 1992. Wagner and Proksch 1985 In: Economic
    and Medicinal Plant Research, Academic
    Press, Orlando, p.113. Wacker & Hilbig. Planta Medica 33(1): 89-102,
    1978. Chone & Mandakis. Deutsch Med.
    Wschr. 27: p. 1406 Luettig, et al. J. Natl. Cancer Inst. 81(9):
    669-75, 1989. Stimpel, et al. Infect. Immun. 46, 845,
    1984; Steinmuller, et al. Int. J. Immunopharmac., Vol. 15, No. 5,
    pp. 605-614, 1993.

  2. "Jan" <[email hidden]> wrote in message
    news:[email hidden]...

    Quoted message said:

    NOT from organized medicine.

    snip

    As predicted.

Active in the last 60 minutes

Active in this thread

0 users · 0 guests ·0 bots ·0 total

No signed-in users are active right now.

No known search crawlers active right now.